Dara Wright - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: Executive Vice President
Issuer ticker: BIO
Reported as of: 01 Sep 2023
Net transaction value: -$185,857
SEC form: 4
Accepted by SEC: 06 Sep 2023, 13:08:49 UTC
Prior SEC filing: 19 Dec 2022
Next SEC filing: 12 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Dara Wright

Filing notes and source

Key filing fact

Dara Wright filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 06 Sep 2023.

Key facts

This page summarizes Dara Wright's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
10 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 06 Sep 2023, 13:08.

Change

Previous filing in this sequence was filed on 19 Dec 2022.
Current net transaction value: -$185,857.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +520
Change %: +29%
Price: $0.000000
Shares after: 2,315
Date: 01 Sep 2023
Ownership: Direct
Footnotes: F1, F2

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $71,028
Shares: -180
Change %: -7.8%
Price: $394.60
Shares after: 2,135
Date: 01 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +405
Change %: +19%
Price: $0.000000
Shares after: 2,540
Date: 01 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $55,639
Shares: -141
Change %: -5.6%
Price: $394.60
Shares after: 2,399
Date: 01 Sep 2023
Ownership: Direct

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +433
Change %: +18%
Price: $0.000000
Shares after: 2,832
Date: 02 Sep 2023
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $59,190
Shares: -150
Change %: -5.3%
Price: $394.60
Shares after: 2,682
Date: 02 Sep 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +3,005
Change %
Price: $0.000000
Shares after: 3,005
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 3,005
Exercise price: $0.000000
Footnotes: F3, F4

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -520
Change %: -25%
Price: $0.000000
Shares after: 1,562
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 520
Exercise price: $0.000000
Footnotes: F3, F5

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -405
Change %: -33%
Price: $0.000000
Shares after: 811
Date: 01 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 405
Exercise price: $0.000000
Footnotes: F3, F6

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -433
Change %: -50%
Price: $0.000000
Shares after: 434
Date: 02 Sep 2023
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 433
Exercise price: $0.000000
Footnotes: F3, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Includes 14.0360 and 18.9240 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F4

The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

Footnote F5

On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F6

On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F7

On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.